Table 2.
Model 1 β (95% CI) P value |
Model 2 β (95% CI) P value |
Model 3 β (95% CI) P value |
|
---|---|---|---|
total alkaline phosphatase (IU/L) | -0.0010 (-0.0012, -0.0008) < 0.000001 | -0.0008(-0.0010, -0.0007) < 0.000001 | -0.0007(-0.0009, -0.0005) < 0.000001 |
total alkaline phosphatase categories | |||
Q1 (7–50) | Reference | Reference | Reference |
Q2 (51–60) | -0.0136 (-0.0237, -0.0035) 0.008490 | -0.0101(-0.0199, -0.0003) 0.042459 | -0.0088(-0.0186, 0.0010) 0.077081 |
Q3 (61–74) | -0.0337(-0.0436, -0.0238) < 0.000001 | -0.0263(-0.0360, -0.0167) < 0.000001 | -0.0235(-0.0333, -0.0138) 0.000002 |
Q4 (75–326) | -0.0603(-0.0704, -0.0502) < 0.000001 | -0.0519(-0.0618, -0.0420) < 0.000001 | -0.0459(-0.0562, -0.0356) < 0.000001 |
P for trend | < 0.001 | < 0.001 | < 0.001 |
Model 1, no covariates were adjusted
Model 2, age, sex, race/ethnicity were adjusted
Model 3, age, sex, race/ethnicity, education, income to poverty ratio, waist circumference, smoking behavior, alcohol consumption, blood urea nitrogen, serum uric acid, total protein, total cholesterol, serum phosphorus, serum calcium and calcium supplementation were adjusted